Influence of testosterone replacement therapy on metabolic disorders in male patients with type 2 diabetes mellitus and androgen deficiency

Table 3 Descriptive characteristics

	Group I before treatment average results (n =43)	Group I after treatment average results (n =43)	Group II before treatment average results (n =42)	Group II after treatment average results (n =42)
BMI	35.65	29.68	36.60	31.88
F.test	3.85	12.06	3.8	6.64
HbA1c	8.26	7.46	8.43	7.93
Leptin	21.71	11.64	23.19	13.93
Chol	211.17	194.64	207.28	198.02
TG	185.6	178.31	182.21	180.23
HDL	55.5	71.11	54	68.44
LDL	102.95	95.62	99.58	96.3

Data are expressed as mean ± SD. BMI: body mass index; Chol: cholesterol; F.test: free testosterone; HbA1c: glycosylated hemoglobin; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol; TC: total cholesterol; TG: triglyceride.

ISSN: 2047-783X